FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carl Dahlöf

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Carl G H Dahlöf; A W Hauge; J Olesen
Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
Carl G H Dahlöf; Maria Johansson; Susanne Casserstedt; Tina Motallebzadeh
The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study.
Carl G H Dahlöf; Agneta Ehrenborg
[Migraine from a female perspective].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carl Dahlöf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Carl G H Dahlöf; A W Hauge; J Olesen
Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
Cephalalgia : an international journal of headache 2009;29 Suppl 2():7-16.
2009: Carl G H Dahlöf; Maria Johansson; Susanne Casserstedt; Tina Motallebzadeh
The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study.
Headache 2009;49(8):1144-52.
2007: Carl G H Dahlöf; Agneta Ehrenborg
[Migraine from a female perspective].
Läkartidningen 2007;104(23):1812-4.
2007: Carl G H Dahlöf; Lars Edvinsson
[Background and treatment of migraine disease].
Läkartidningen 2007;104(23):1806-10.
2007: Carl G H Dahlöf; Elizabeth Loder; Merle Diamond; Marcia F T Rupnow; George Papadopoulos; Lian Mao
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
Health and quality of life outcomes 2007;5():56.
2007: Peter J Goadsby; Hélène Massiou; J Pascual; Hans-Christoph Diener; Carl G H Dahlöf; V Mateos; Andrew J Dowson; I Raets; L Cunha; M Färkkilä; G C Manzoni
Almotriptan and zolmitriptan in the acute treatment of migraine.
Acta neurologica Scandinavica 2007;115(1):34-40.
2006: Carl G H Dahlöf
Cutaneous allodynia and migraine: another view.
Current pain and headache reports 2006;10(3):231-8.
2006: Mattias Linde; A Mellberg; Carl G H Dahlöf
The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan.
Cephalalgia : an international journal of headache 2006;26(6):712-21.
2006: Carl G H Dahlöf; J Pascual; D W Dodick; Andrew J Dowson
Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Cephalalgia : an international journal of headache 2006;26(4):400-8.
2006: Mattias Linde; A Mellberg; Carl G H Dahlöf
Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
Cephalalgia : an international journal of headache 2006;26(2):113-21.
2006: Carl G H Dahlöf
Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
Cephalalgia : an international journal of headache 2006;26(2):98-106.
2005: G Sandrini; Carl G H Dahlöf; N Mathew; G Nappi
Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
International journal of clinical practice 2005;59(11):1356-65.
2005: Carl G H Dahlöf; P Linton-Dahlöf; J M Lainez; J Pascual
[Is migraine a progressive cerebral disease?].
Neurología (Barcelona, Spain) 2005;20(7):356-65.
2005: Merle Diamond; Carl G H Dahlöf; George Papadopoulos; Walter Neto; S-C Wu
Topiramate improves health-related quality of life when used to prevent migraine.
Headache 2005;45(8):1023-30.
2005: Andrew J Dowson; Stewart J Tepper; Carl G H Dahlöf
Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine.
The journal of headache and pain 2005;6(3):112-20.
2005: Carl G H Dahlöf
Non-oral formulations of triptans and their use in acute migraine.
Current pain and headache reports 2005;9(3):206-12.
2005: Fred D Sheftell; Carl G H Dahlöf; Jan Lewis Brandes; Reto Agosti; Martin W Jones; Pamela S Barrett
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Clinical therapeutics 2005;27(4):407-17.
2005: Mattias Linde; A Fjell; J Carlsson; Carl G H Dahlöf
Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study.
Cephalalgia : an international journal of headache 2005;25(1):41-7.
2004: Mattias Linde; Mikael Elam; L Lundblad; Håkan Olausson; Carl G H Dahlöf
Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia.
Cephalalgia : an international journal of headache 2004;24(12):1057-66.
2004: Carl G H Dahlöf
[Can migraine cause subclinical brain lesions? A Dutch study shows a connection--but more research is required].
Läkartidningen 2004;101(47):3782, 3785-6, 3788.
2004: Stewart J Tepper; Carl G H Dahlöf; Andrew J Dowson; Lawrence Newman; Hank Mansbach; Martin Jones; Ba Pham; Chris Webster; Reijo Salonen
Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
Headache 2004;44(9):856-64.
2004: Hans-Christoph Diener; Peer Tfelt-Hansen; Carl G H Dahlöf; Miguel J A Láinez; Giorgio Sandrini; Shuu-Jiun Wang; Walter Neto; Ujjwalla Vijapurkar; Aiden Doyle; David Jacobs
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.
Journal of neurology 2004;251(8):943-50.
2004: Randolph W Evans; Carl G H Dahlöf
Determining triptan preference for the individual patient.
Headache 2004;44(7):723-5.
2004: Mattias Linde; Carl G H Dahlöf
Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.
Cephalalgia : an international journal of headache 2004;24(6):455-65.
2004: Mattias Linde; Carl G H Dahlöf
[Prophylactic bedrest against post-lumbar puncture headache should not be routinely used in all patients].
Läkartidningen 2004;101(6):466-9.
2003: Mark Kosinski; martha bayliss; Jakob B Bjorner; John Ware; W H Garber; Alice S Batenhorst; R Cady; Carl G H Dahlöf; Andrew J Dowson; S Tepper
A six-item short-form survey for measuring headache impact: the HIT-6.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(8):963-74.
2003: John Ware; Mark Kosinski; Jakob B Bjorner; martha bayliss; Alice S Batenhorst; Carl G H Dahlöf; Stewart Tepper; Andrew J Dowson
Applications of computerized adaptive testing (CAT) to the assessment of headache impact.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(8):935-52.
2003: Mattias Linde; A May; V Limmroth; Carl G H Dahlöf
Ethical aspects of placebo in migraine research.
Cephalalgia : an international journal of headache 2003;23(7):491-5.
2003: Carl G H Dahlöf
Measuring disability and quality of life in migraine.
Drugs of today (Barcelona, Spain : 1998) 2003;39 Suppl D():17-23.
2002: Carl G H Dahlöf
Integrating the triptans into clinical practice.
Current opinion in neurology 2002;15(3):317-22.
2002: Carl G H Dahlöf; David Dodick; Andrew J Dowson; Julio Pascual
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
Headache 2002;42(2):99-113.
2002: David W Dodick; Stephen Silberstein; Carl G H Dahlöf
Is there a preferred triptan?
Headache 2002;42(1):1-7.
2001: Carl G H Dahlöf; Peer Tfelt-Hansen; H Massiou; A Fazekas
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine.
Neurology 2001;57(10):1811-7.
2001: H C Diener; Peer Tfelt-Hansen; F de Beukelaar; M D Ferrari; J Olesen; Carl G H Dahlöf; N Mathew
The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial.
Cephalalgia : an international journal of headache 2001;21(6):672-9.
2001: Carl G H Dahlöf; Mattias Linde
One-year prevalence of migraine in Sweden: a population-based study in adults.
Cephalalgia : an international journal of headache 2001;21(6):664-71.
2001: P Linton-Dahlöf; Mattias Linde; Carl G H Dahlöf
[A vicious circle when headache medication is the cause of chronic headache. A well-planned ambulatory detoxication can result in dramatic improvement].
Läkartidningen 2001;98(26-27):3128-31.
2001: Carl G H Dahlöf
Sumatriptan: pharmacological basis and clinical results.
Current medical research and opinion 2001;17 Suppl 1():s35-45.
2000: Carl G H Dahlöf; richard lipton; Kathleen McCarroll; M S Kramer; Christopher R Lines; M D Ferrari
Within-patient consistency of response of rizatriptan for treating migraine.
Neurology 2000;55(10):1511-6.
2000: Peer Tfelt-Hansen; G Block; Carl G H Dahlöf; H C Diener; M D Ferrari; P J Goadsby; Vincenzo Guidetti; B Jones; richard lipton; H Massiou; C Meinert; Giorgio Sandrini; T Steiner; P B Winter
Guidelines for controlled trials of drugs in migraine: second edition.
Cephalalgia : an international journal of headache 2000;20(9):765-86.
2000: P Linton-Dahlöf; Mattias Linde; Carl G H Dahlöf
Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study.
Cephalalgia : an international journal of headache 2000;20(7):658-62.
2000: Peer Tfelt-Hansen; P R Saxena; Carl G H Dahlöf; J Pascual; Miguel J A Láinez; P Henry; H Diener; J Schoenen; M D Ferrari; P J Goadsby
Ergotamine in the acute treatment of migraine: a review and European consensus.
Brain : a journal of neurology 2000;123 ( Pt 1)():9-18.
1999: Carl G H Dahlöf
Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.
Cephalalgia : an international journal of headache 1999;19(9):769-78.
1999: Carl G H Dahlöf
How to assess patient preference of migraine treatments.
Cephalalgia : an international journal of headache 1999;19 Suppl 24():2-5; discussion 5-6.
1999: Carl G H Dahlöf
Current concepts of migraine and its treatment.
Neurología (Barcelona, Spain) 1999;14(2):67-77.
1998: Carl G H Dahlöf; L Falk; M Risenfors; C P Lewis
Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.
Cephalalgia : an international journal of headache 1998;18(8):546-51.
1998: Carl G H Dahlöf; N Mathew
Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?
Cephalalgia : an international journal of headache 1998;18(8):539-45.
1998: J E Hardebo; Carl G H Dahlöf
Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache.
Cephalalgia : an international journal of headache 1998;18(7):487-9.
1998: Carl G H Dahlöf; S Boes-Hansen; C G Cederberg; J E Hardebo; A Henriksson
How does sumatriptan nasal spray perform in clinical practice?
Cephalalgia : an international journal of headache 1998;18(5):278-82.
1997: Carl G H Dahlöf
Would any acute treatment for migraine demonstrate recurrence?
Cephalalgia : an international journal of headache 1997;17 Suppl 17():17-9; discussion 19-20.
1997: J Bouchard; Pietro Cortelli; Carl G H Dahlöf; J Heywood; JP Jansen; K L Price; S Pham; A Joseph; L Babiak
A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction.
PharmacoEconomics 1997;11 Suppl 1():43-50.
1997: Pietro Cortelli; Carl G H Dahlöf; J Bouchard; J Heywood; JP Jansen; S Pham; J Hirsch; Jim Adams; D W Miller
A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activity.
PharmacoEconomics 1997;11 Suppl 1():35-42.
1997: Carl G H Dahlöf; J Bouchard; Pietro Cortelli; J Heywood; JP Jansen; S Pham; J Hirsch; Jim Adams; D W Miller
A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.
PharmacoEconomics 1997;11 Suppl 1():24-34.
1997: J Heywood; J Bouchard; Pietro Cortelli; Carl G H Dahlöf; JP Jansen; S Pham; J Hirsch; C E Edwards; Jim Adams; Patrizia Berto; B Brueggenjuergen; A L Nyth; P Lindsay; K L Price
A multinational investigation of the impact of subcutaneous sumatriptan. I: Design, methods and clinical findings.
PharmacoEconomics 1997;11 Suppl 1():11-23.
1996: Tommy Nederfors; Carl G H Dahlöf
Effects on salivary flow rate and composition of withdrawal of and re-exposure to the beta 1-selective antagonist metoprolol in a hypertensive patient population.
European journal of oral sciences 1996;104(3):262-8.
1996: Carl G H Dahlöf; L D Jacobs
Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache.
Cephalalgia : an international journal of headache 1996;16(2):117-23.
1995: Stefan Agewall; John Wikstrand; Carl G H Dahlöf; Björn Fagerberg
A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk.
Journal of hypertension 1995;13(12 Pt 1):1471-7.
1995: Carl G H Dahlöf
How does sumatriptan perform in clinical practice?
Cephalalgia : an international journal of headache 1995;15 Suppl 15():21-8.
1995: Carl G H Dahlöf; E Dimenäs
Migraine patients experience poorer subjective well-being/quality of life even between attacks.
Cephalalgia : an international journal of headache 1995;15(1):31-6.
1994: Rob P Coppes; J Smit; A M Geurtsen; AF Roffel; Carl G H Dahlöf; H N Doods; Johan Zaagsma
Heterogeneity of prejunctional neuropeptide Y receptors inhibiting noradrenaline overflow in the portal vein of freely moving rats.
European journal of pharmacology 1994;261(3):311-6.
1994: Tommy Nederfors; Carl G H Dahlöf; Svante Twetman
Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human unstimulated whole saliva flow rate and protein composition.
Scandinavian journal of dental research 1994;102(4):235-7.
1994: V I Tarizzo; Rob P Coppes; Carl G H Dahlöf; Johan Zaagsma
Pre- and postganglionic stimulation-induced noradrenaline overflow is markedly facilitated by a prejunctional beta 2-adrenoceptor-mediated control mechanism in the pithed rat.
Naunyn-Schmiedeberg's archives of pharmacology 1994;349(6):570-7.
1994: Carl G H Dahlöf; P Linton-Dahlöf; J M Lundberg
Tetrodotoxin-sensitive release of adrenaline, noradrenaline and neuropeptide Y-like immunoreactivity in the pithed guinea-pig in the absence of electrical preganglionic nerve stimulation.
Journal of neuroscience methods 1994;52(2):215-8.
1994: Tommy Nederfors; T Ericsson; Svante Twetman; Carl G H Dahlöf
Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human parotid and submandibular-sublingual salivary secretion.
Journal of dental research 1994;73(1):5-10.
1993: Tommy Nederfors; Carl G H Dahlöf
A modified device for collection and flow-rate measurement of submandibular-sublingual saliva.
Scandinavian journal of dental research 1993;101(4):210-4.
1993: Carl G H Dahlöf
Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine.
Cephalalgia : an international journal of headache 1993;13(3):166-71.
1993: Tommy Nederfors; V Henricsson; Carl G H Dahlöf; Tony Axéll
Oral mucosal friction and subjective perception of dry mouth in relation to salivary secretion.
Scandinavian journal of dental research 1993;101(1):44-8.
1992: Carl G H Dahlöf; C Alm; I Bertling; L Barret
Cytochrome P-450-dependent hydroxylation in migraine.
Cephalalgia : an international journal of headache 1992;12(3):158-60.
1992: Carl G H Dahlöf; E Dimenäs
General well-being during treatment with different ACE-inhibitors: two double-blind placebo-controlled cross-over studies in healthy volunteers.
European journal of clinical pharmacology 1992;43(4):375-9.
1992: Tommy Nederfors; Carl G H Dahlöf
Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human whole saliva flow rate and composition.
Archives of oral biology 1992;37(7):579-84.
1991: Carl G H Dahlöf; E Dimenäs; M Kendall; Ingela Wiklund
Quality of life in cardiovascular diseases. Emphasis on beta-blocker treatment.
Circulation 1991;84(6 Suppl):VI108-18.
1991: XY Sun; Carl G H Dahlöf; Lars Edvinsson; Thomas Hedner
D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
European journal of pharmacology 1991;204(3):281-6.
1991: P Dahlöf; V I Tarizzo; J M Lundberg; Carl G H Dahlöf
Alpha- and beta-adrenoceptor-mediated effects on nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea pig.
Journal of the autonomic nervous system 1991;35(3):199-210.
1991: P Dahlöf; J M Lundberg; Carl G H Dahlöf
Effect of captopril on plasma levels of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea pig.
Neuropeptides 1991;18(4):171-80.
1990: Carl G H Dahlöf; E Dimenäs
Side effects of beta-blocker treatments as related to the central nervous system.
The American journal of the medical sciences 1990;299(4):236-44.
1990: E Dimenäs; Carl G H Dahlöf
Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.
Journal of clinical pharmacology 1990;30(2 Suppl):S92-7.
1990: E Dimenäs; J Ostergren; K Lindvall; Carl G H Dahlöf; G Westergren; U de Faire
Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
Journal of clinical pharmacology 1990;30(2 Suppl):S82-90.
1990: E S Dimenäs; Carl G H Dahlöf; B Heibel; R G Moore; B K Olofsson; G E Westergren; P W Lücker
Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.
European journal of clinical pharmacology 1990;38(6):571-8.
1990: E S Dimenäs; Carl G H Dahlöf; S C Jern; Ingela Wiklund
Defining quality of life in medicine.
Scandinavian journal of primary health care. Supplement 1990;1():7-10.
1990: Carl G H Dahlöf
Quality of life/subjective symptoms during beta-blocker treatment.
Scandinavian journal of primary health care. Supplement 1990;1():73-80.
1990: Carl G H Dahlöf
Minor Symptoms Evaluation (MSE) Profile--a questionnaire for assessment of subjective CNS-related symptoms.
Scandinavian journal of primary health care. Supplement 1990;1():19-25.
1989: Tommy Nederfors; Svante Twetman; Carl G H Dahlöf
Effects of the thiazide diuretic bendroflumethiazide on salivary flow rate and composition.
Scandinavian journal of dental research 1989;97(6):520-7.
1989: Carl G H Dahlöf; E Dimenäs; B Olofsson
Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1989;3(6):919-27.
1989: E S Dimenäs; Ingela Wiklund; Carl G H Dahlöf; K G Lindvall; B K Olofsson; U H De Faire
Differences in the subjective well-being and symptoms of normotensives, borderline hypertensives and hypertensives.
Journal of hypertension 1989;7(11):885-90.
1989: E Dimenäs; Carl G H Dahlöf; B Olofsson; Ingela Wiklund
CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.
British journal of clinical pharmacology 1989;28(5):527-34.
1989: V I Tarizzo; Carl G H Dahlöf
Adrenaline-induced enhancement of the blood pressure response to sympathetic nerve stimulation in adrenal demedullated pithed rats.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(2):144-50.
1988: Carl G H Dahlöf; G Almkvist; E Dimenäs; Sverker Jern; B Johansson; C Larsson; S Lorentzon; D Nilsson; L Nygaard-Pedersen
No difference in general well-being during antihypertensive treatment with atenolol or metoprolol CR.
Annals of clinical research 1988;20 Suppl 48():42-50.
1988: P Dahlöf; K Persson; J M Lundberg; Carl G H Dahlöf
Neuropeptide Y (NPY) induced inhibition of preganglionic nerve stimulation evoked release of adrenalin and noradrenaline in the pithed rat.
Acta physiologica Scandinavica 1988;132(1):51-7.
1988: Claes-Göran AH Löfdahl; Carl G H Dahlöf; G Westergren; B Olofsson; N Svedmyr
Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
European journal of clinical pharmacology 1988;33 Suppl():S25-32.
1986: Carl G H Dahlöf; P Dahlöf; J M Lundberg
Alpha 2-adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig.
European journal of pharmacology 1986;131(2-3):279-83.
1985: Carl G H Dahlöf; P Dahlöf; J M Lundberg
Neuropeptide Y (NPY): enhancement of blood pressure increase upon alpha-adrenoceptor activation and direct pressor effects in pithed rats.
European journal of pharmacology 1985;109(2):289-92.
1985: Carl G H Dahlöf; P Dahlöf; K Tatemoto; J M Lundberg
Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein.
Naunyn-Schmiedeberg's archives of pharmacology 1985;328(3):327-30.